Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Podiatr Med Assoc ; 108(2): 172-177, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29135278

RESUMO

Acral fibrokeratoma is a rare soft-tissue mass, more commonly found on the hands and rarely on the feet. This case report of a 40-year-old Hispanic man highlights an unusually located acral fibrokeratoma on the second toe, describes the clinical presentation and microscopic and pathologic findings, discusses differential diagnoses, and presents treatment options.


Assuntos
Neoplasias de Tecidos Moles/patologia , Dedos do Pé/patologia , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Neoplasias de Tecidos Moles/cirurgia , Dedos do Pé/cirurgia
2.
Food Chem Toxicol ; 52: 207-15, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23182741

RESUMO

Green tea polyphenol epigallocatechin gallate (EGCG) is a strong antioxidant that has previously been shown to reduce the number of plaques in HIV-infected cultured cells. Modified EGCG, palmitoyl-EGCG (p-EGCG), is of interest as a topical antiviral agent for herpes simplex virus (HSV-1) infections. This study evaluated the effect of p-EGCG on HSV-infected Vero cells. Results of cell viability and cell proliferation assays indicate that p-EGCG is not toxic to cultured Vero cells and show that modification of the green tea polyphenol epigallocatechin gallate (EGCG) with palmitate increases the effectiveness of EGCG as an antiviral agent. Furthermore, p-EGCG is a more potent inhibitor of herpes simplex virus 1 (HSV-1) than EGCG and can be topically applied to skin, one of the primary tissues infected by HSV. Viral binding assay, plaque forming assay, PCR, real-time PCR, and fluorescence microscopy were used to demonstrate that p-EGCG concentrations of 50 µM and higher block the production of infectious HSV-1 particles. p-EGCG was found to inhibit HSV-1 adsorption to Vero cells. Thus, p-EGCG may provide a novel treatment for HSV-1 infections.


Assuntos
Antivirais/farmacologia , Catequina/análogos & derivados , Herpesvirus Humano 1/efeitos dos fármacos , Chá/química , Animais , Antígenos Virais/genética , Antivirais/química , Catequina/química , Catequina/farmacologia , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Chlorocebus aethiops , Relação Dose-Resposta a Droga , Regulação Viral da Expressão Gênica/efeitos dos fármacos , Proteínas de Fluorescência Verde/genética , Herpes Simples/tratamento farmacológico , Herpesvirus Humano 1/genética , Herpesvirus Humano 1/metabolismo , Microscopia de Fluorescência , Células Vero/efeitos dos fármacos , Células Vero/virologia , Proteínas do Envelope Viral/genética , Proteínas Virais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...